Data sourced from ClinicalTrials.gov (NIH registry) Updated weekly IRB-supervised studies only
Home/CA/Santa Rosa
Updated September 2026 from ClinicalTrials.gov

Paid Clinical Trials in Santa Rosa, CA

Studies commonly pay $75 to $4,500 per completed study

145 clinical trials are currently recruiting participants within 30 miles of Santa Rosa. Listings below come straight from the official NIH registry, alongside the area's top-rated research centers with real Google reviews.

145studies recruiting
8+research centers nearby
5condition categories
Live from the NIH registry

Studies recruiting near Santa Rosa right now

Top 25 of 145 recruiting studies, sorted by proximity — each links to its official registry page

Testing Shorter Duration Radiation Therapy Versus the Usual Radiation Therapy in Patients With High Risk Prostate Cancer

Prostate Adenocarcinoma, Stage III Prostate Cancer AJCC v8 Phase 3 Interventional 1,209 participants sought
Kaiser Permanente-Santa Rosa — Santa Rosa, California (0.6 mi) · Sponsor: NRG Oncology

A Global Study of Volrustomig (MEDI5752) for Participants With Unresected Locally Advanced Head and Neck Squamous Cell Carcinoma Following Definitive Concurrent Chemoradiotherapy

Locally Advanced Head and Neck Squamous Cell Carcinoma Phase 3 Interventional 1,145 participants sought
Research Site — Santa Rosa, California (0.6 mi) · Sponsor: AstraZeneca

A Study to Assess Adverse Events and Effectiveness of Gel Stent (XEN63) Implantation Using Ab Interno and Ab Externo Approaches in Adult Participants With Glaucoma

Primary Open Angle Glaucoma Phase 3 Interventional 130 participants sought
North Bay Eye Associates /ID# 277071 — Petaluma, California (15.2 mi) · Sponsor: AbbVie

High-dose Prophylactic Gabapentin (HOPE) vs. Placebo to Prevent Opioid Use for Oral Mucositis Pain During Concurrent Chemoradiation for Head and Neck Cancer

Head and Neck Squamous Cell Carcinoma, Stage I Head and Neck Cutaneous Squamous Cell Carcinoma AJCC v8 Phase 3 Interventional 228 participants sought
Kaiser Permanente-Santa Rosa — Santa Rosa, California (0.6 mi) · Sponsor: Alliance for Clinical Trials in Oncology

Testing Docetaxel-Cetuximab or the Addition of an Immunotherapy Drug, Atezolizumab, to the Usual Chemotherapy and Radiation Therapy in High-Risk Head and Neck Cancer

Oropharyngeal p16INK4a-Negative Squamous Cell Carcinoma, Stage III Hypopharyngeal Squamous Cell Carcinoma AJCC v7 Phase 2, Phase 3 Interventional 613 participants sought
Saint Helena Hospital — St. Helena, California (13.4 mi) · Sponsor: National Cancer Institute (NCI)

Testing the Addition of Stereotactic Radiation Therapy With Immune Therapy for the Treatment of Patients With Unresectable or Metastatic Renal Cell Cancer, SAMURAI Trial

Metastatic Renal Cell Carcinoma, Stage III Renal Cell Cancer AJCC v8 Phase 2 Interventional 240 participants sought
Sutter Pacific Medical Foundation — Santa Rosa, California (0.6 mi) · Sponsor: NRG Oncology

A Study of Amivantamab and mFOLFOX6 or FOLFIRI Versus Cetuximab and mFOLFOX6 or FOLFIRI as First-line Treatment in Participants With KRAS/NRAS and BRAF Wild-type Unresectable or Metastatic Left-sided Colorectal Cancer

Colorectal Neoplasms Phase 3 Interventional 1,000 participants sought
Providence Medical Foundation — Santa Rosa, California (0.6 mi) · Sponsor: Janssen Research & Development, LLC

Comparing the Outcome of Immunotherapy-Based Drug Combination Therapy With or Without Surgery to Remove the Kidney in Metastatic Kidney Cancer, the PROBE Trial

Metastatic Clear Cell Renal Cell Carcinoma, Metastatic Renal Cell Carcinoma Phase 3 Interventional 364 participants sought
Sutter Pacific Medical Foundation — Santa Rosa, California (0.6 mi) · Sponsor: SWOG Cancer Research Network

Symbiotic-GI-03: A Study to Learn About the Study Medicine Called PF-08634404 in Combination With Chemotherapy in Adult Participants With Metastatic Colorectal Cancer

Intestinal Neoplasms, Gastrointestinal Neoplasms Phase 3 Interventional 800 participants sought
Airway Drive Care Center — Santa Rosa, California (0.6 mi) · Sponsor: Pfizer

Study of Trastuzumab Deruxtecan, Pembrolizumab, and Platinum-based Chemotherapy in First-line HER2 Overexpressing Non-small Cell Lung Cancer

Non-small Cell Lung Cancer Phase 3 Interventional 686 participants sought
Providence Medical Foundation — Santa Rosa, California (0.6 mi) · Sponsor: Daiichi Sankyo

RE104 Safety and Efficacy Study in Adjustment Disorder in Cancer and Other Medical Illnesses

Adjustment Disorder Phase 2 Interventional 100 participants sought
Providence Medical Foundation — Santa Rosa, California (0.6 mi) · Sponsor: Reunion Neuroscience Inc

Drug-Eluting Registry: Real-World Treatment of Lesions in the Peripheral Vasculature

Peripheral Vascular Diseases N/A Observational 5,000 participants sought
Adventist Health St Helena Hospital — St. Helena, California (13.4 mi) · Sponsor: Boston Scientific Corporation

Adding an Immunotherapy Drug, MEDI4736 (Durvalumab), to the Usual Chemotherapy Treatment (Paclitaxel, Cyclophosphamide, and Doxorubicin) for Stage II-III Breast Cancer

Anatomic Stage II Breast Cancer AJCC v8, Anatomic Stage III Breast Cancer AJCC v8 Phase 3 Interventional 3,680 participants sought
Providence Medical Foundation - Santa Rosa — Santa Rosa, California (0.6 mi) · Sponsor: National Cancer Institute (NCI)

A Study to Evaluate the Efficacy, Safety, Pharmacodynamics (PD), and Pharmacokinetics (PK) of Selnoflast in Reducing Vascular Inflammation in Participants With Atherosclerosis at Risk for Major Adverse Cardiac Events

Atherosclerosis Phase 2 Interventional 162 participants sought
NorthBay Clinical Research — Santa Rosa, California (0.6 mi) · Sponsor: Genentech, Inc.

Inotuzumab Ozogamicin and Frontline Chemotherapy in Treating Young Adults With Newly Diagnosed B Acute Lymphoblastic Leukemia

B Acute Lymphoblastic Leukemia Phase 3 Interventional 303 participants sought
Kaiser Permanente-Santa Rosa — Santa Rosa, California (0.6 mi) · Sponsor: Alliance for Clinical Trials in Oncology

Testing the Addition of Docetaxel (Chemotherapy) to the Usual Treatment (Hormonal Therapy and Apalutamide) for Metastatic Prostate Cancer, ASPIRE Trial

Castration-Sensitive Prostate Carcinoma, Metastatic Prostate Adenocarcinoma Phase 3 Interventional 1,260 participants sought
Kaiser Permanente-Santa Rosa — Santa Rosa, California (0.6 mi) · Sponsor: Alliance for Clinical Trials in Oncology

A Study to Investigate Efficacy, Safety and Tolerability of Barzolvolimab Versus Placebo in Adults With Cold Induced Urticaria and Symptomatic Dermographism Inadequately Controlled by H1-antihistamines (EMBARQ - ColdU and SD)

Chronic Inducible Urticaria, Cold Urticaria Phase 3 Interventional 240 participants sought
One of a Kind Clinical Research Center — Napa, California (25.0 mi) · Sponsor: Celldex Therapeutics

Phase Ib Study of the Safety of T-DXd and Immunotherapy Agents With and Without Chemotherapy in Advanced or Metastatic HER2+, Non-squamous NSCLC

Locally Advanced or Metastatic Non-Small Cell Lung Cancer Phase 1 Interventional 304 participants sought
Research Site — Santa Rosa, California (0.6 mi) · Sponsor: AstraZeneca

Study to Evaluate Safety, Efficacy and Immunogenicity of Acne mRNA Vaccine in Adults With Moderate to Severe Acne

Acne Phase 1, Phase 2 Interventional 800 participants sought
NorthBay Clinical Research- Site Number : 8400066 — Santa Rosa, California (0.6 mi) · Sponsor: Sanofi Pasteur, a Sanofi Company

Study of INBRX-106 and INBRX-106 in Combination With Pembrolizumab (Keytruda®) in Subjects With Locally Advanced or Metastatic Solid Tumors (Hexavalent OX40 Agonist)

Solid Tumor, Non-Small Cell Lung Cancer Phase 1, Phase 2 Interventional 340 participants sought
Providence Medical Foundation — Santa Rosa, California (0.6 mi) · Sponsor: Inhibrx Biosciences, Inc

A Study of ART0380 for the Treatment of Advanced or Metastatic Solid Tumors

Advanced Cancer, Metastatic Cancer Phase 1, Phase 2 Interventional 542 participants sought
Providence Medical Foundation — Santa Rosa, California (0.6 mi) · Sponsor: Artios Pharma Ltd
Actively enrolling

Studies you may be able to join near Santa Rosa

These studies are recruiting through partner research networks. We may be paid a referral fee if you complete their screening form — this never changes what you pay (nothing) or the compensation the study offers you.

See which clinical studies you may qualify for

A partner research network matches volunteers with studies that are currently enrolling in the United States. You answer a few screening questions about your health and where you live; if a study looks like a fit, its team contacts you to confirm eligibility.

Screening is free and takes a few minutes. Eligibility and any compensation are confirmed by the study team, not by this site.

Google-rated

Top-rated research centers in Santa Rosa

Dedicated clinical research sites near you — with their real Google ratings, reviews and contact details

Providence Medical Group Santa Rosa - Clinical Trials

3555 Round Barn Cir, Santa Rosa, CA 95403
(707) 521-3830

Siyan Clinical Corporation

★ 4.8 (564 reviews)
480 Tesconi Cir Ste B, Santa Rosa, CA 95401
(707) 206-7268

TrueNorth Health Center

★ 4.4
1551 Pacific Ave, Santa Rosa, CA 95404
(707) 586-5555

Santa Rosa Behavioral Healthcare Hospital

★ 2.2 (244 reviews)
1287 Fulton Rd, Santa Rosa, CA 95401
(707) 800-7700
"Everyone that works there (except for the kitchen staff) knows how to treat people and do their best even when others (patience) are not trying to he…"
— Lamar Manuel, 5★

Sunwise Clinical Research

★ 4.7
1371 Oakland Blvd #301, Walnut Creek, CA 94596
(925) 298-5147
"They are a great group of people"
— Tree Sap, 5★

Evolve Restorative Center

★ 4.1 (53 reviews)
220 Concourse Blvd, Santa Rosa, CA 95403
(844) 527-7369
"First time I've been to this practice....and it will be my last. Looks like a nice facility but staff are robotic and appear to care less about thei…"
— Mike Antill, 1★

Oakland Clinical

3300 Webster St #1106, Oakland, CA 94609
(510) 817-2000

CPMC Research Institute

★ 5.0
2330 Clay St, San Francisco, CA 94115
(415) 561-1785

Clinical trials in Santa Rosa: what's recruiting

The Santa Rosa area currently has 145 studies open to new participants, according to the ClinicalTrials.gov registry maintained by the U.S. National Institutes of Health. Among the studies closest to Santa Rosa, the most active research areas are:

  • Cancer & Oncology15 studies
  • Liver & Kidney4 studies
  • Heart & Vascular2 studies
  • Lungs & Breathing1 studies
  • Immune & Skin1 studies

Every listing shows the study phase, the recruiting site and its distance from Santa Rosa, and links to the official registry page where eligibility criteria and study contacts are published. Compensation is set by each sponsor: industry surveys report typical payments of $75 to $4,500 per completed study, with short observational studies at the low end and multi-visit or overnight Phase 1 studies at the high end.

How to enroll in a paid study in Santa Rosa

Start with a study whose condition matches your profile — or a healthy-volunteer study if you have no diagnosis. Contact the research site through the registry page, complete a short phone screen, then attend an in-person screening visit. If you qualify, the study team walks you through the informed consent document, which details every procedure, risk and payment before you commit. You can withdraw at any point, and enrollment is always free.

Santa Rosa participants can also register with the dedicated research centers listed above — many maintain volunteer databases and call when a matching study opens — or sign up for our email alert below to hear when a new study starts recruiting within 30 miles of your ZIP code.

Frequently asked questions

How much do paid clinical trials in Santa Rosa pay?
Compensation varies by study length, procedures and overnight stays. Industry surveys report typical payments from $75 to $4,500 per completed study, with simple observational studies at the low end and multi-week inpatient Phase 1 studies at the high end. Each listing's study team will confirm the exact amount before you enroll.
Are clinical trials in Santa Rosa safe?
Every trial on this page is registered on ClinicalTrials.gov, the official NIH registry, and is overseen by an Institutional Review Board (IRB). Before joining you receive an informed consent document detailing procedures, risks and compensation. Participation is voluntary and you can withdraw at any time.
How do I join a study in Santa Rosa, CA?
Pick a study that matches your profile, contact the research site (or apply through the study links on this page), pass a phone pre-screen, then attend an in-person screening visit. If you qualify, you review and sign the informed consent and the study begins. The process typically takes 1-3 weeks.
What is the difference between a research center and a hospital study in Santa Rosa?
Dedicated research centers (listed on this page with their Google ratings) run studies as their core business — often healthy-volunteer and vaccine studies with structured compensation. Hospital and university studies tend to focus on patients with specific conditions. Both types are registered and IRB-supervised.
Can I be in more than one clinical trial at a time?
Generally no — most studies exclude participants currently enrolled in another trial, and paid Phase 1 studies enforce a washout period (often 30 days or more) between studies. Frequent healthy volunteers in Santa Rosa typically complete one or two studies per year.

Paid clinical trials near Santa Rosa

Other metros within reach

By condition

Eligibility and exclusions, condition by condition

More of CA

New paid studies open every week

Get an email when a new clinical trial starts recruiting within 30 miles of your ZIP code. No spam — only real studies from the NIH registry.

Get free trial alerts